During the past decade, Bryn Mawr Urology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bryn Mawr Urology" are "Prostate Cancer" (1 trials) and "Urethral Stricture" (1 trials). Many other conditions were trialed in "Bryn Mawr Urology" in a lesser frequency.

Most popular intervention types in "Bryn Mawr Urology" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Memokath stenting" (1 trials), "Placebo" (1 trials) and "sipuleucel-T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bryn Mawr Urology" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bryn Mawr Urology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bryn Mawr Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bryn Mawr Urology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".